| dbo:abstract
|
- John Kopchick is a molecular biologist and co-inventor of the drug Somavert (Pegvisomant), which has improved the lives of acromegalic individuals around the world. He is currently the Goll-Ohio Eminent Scholar and Professor of Molecular Biology in the Department of Biomedical Sciences at the Ohio University Heritage College of Osteopathic Medicine. Dr. Kopchick's groundbreaking work in the field of growth hormone has helped shape the study of endocrinology. (en)
|
| dbo:academicDiscipline
| |
| dbo:almaMater
| |
| dbo:birthDate
| |
| dbo:birthPlace
| |
| dbo:knownFor
| |
| dbo:nationality
| |
| dbo:residence
| |
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 17482 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:almaMater
| |
| dbp:birthDate
| |
| dbp:birthPlace
| |
| dbp:caption
|
- John Kopchick moderating a session at The Endocrine Society's 93rd Annual Meeting, Boston 2011 (en)
|
| dbp:field
| |
| dbp:knownFor
|
- Growth Hormone Research (en)
|
| dbp:name
| |
| dbp:nationality
| |
| dbp:prizes
|
- British Society for Endocrinology’s Transatlantic Medal (en)
|
| dbp:residence
| |
| dbp:wikiPageUsesTemplate
| |
| dbp:workInstitutions
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- John Kopchick is a molecular biologist and co-inventor of the drug Somavert (Pegvisomant), which has improved the lives of acromegalic individuals around the world. He is currently the Goll-Ohio Eminent Scholar and Professor of Molecular Biology in the Department of Biomedical Sciences at the Ohio University Heritage College of Osteopathic Medicine. Dr. Kopchick's groundbreaking work in the field of growth hormone has helped shape the study of endocrinology. (en)
|
| rdfs:label
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
